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Abstract
A behavioral form of impulsivity, delay discounting, has been used to examine the effects
of drug consumption on individuals’ abilities to delay gratification. However, delay
discounting has not been used to examine one of the most commonly used drugs in the
world, caffeine. Nor has delay discounting been used to examine the effects of drug
influence on impulsivity. This study examined the influence of 200 mg caffeine on delay
discounting in a collegiate sample. 15 participants underwent two experimental sessions:
a caffeine condition and a placebo condition. Although participants were more impulsive
under caffeine than under placebo, this trend was non-significant. This study does
however provide a good model for evaluating the influence of drug state on impulsivity.

v

Introduction
Impulsivity is a characteristic of various mental disorders including mania, obsessivecompulsive disorder, attention-deficit/hyperactivity disorder, and substance abuse
disorders (APA, 1994). Despite prevalence in not only psychopathic, but everyday
behaviors, no one singular definition of impulsivity exists (Evenden, 1999). Researchers
have operationally defined impulsivity as the inability to inhibit inappropriate responses,
the tendency to act without considering consequences, and the inability to delay
gratification, to name a few (Ainslie, 1975; Barkley, 1997). While most researchers
agree that impulsivity is multidimensional, researchers still disagree as to which
components should be included in the definition of impulsivity (Whiteside & Lynam,
2001; Zuckerman, 1971). Furthermore, debate has risen over whether impulsivity is a
stable personality trait (e.g. Moeller, Barratt, Dougherty, Schmitz, & Swann, 2001) or a
description of a malleable state (e.g., Lowenstien, 1996). Other researchers have argued
that impulsivity is both a state and trait (Wingrove & Bond, 1996).
Due to the lack of consensus of a definition of impulsivity, multiple assessments have
been developed, which operate under various models of impulsivity. These measures
generally fall under two categories: self-report questionnaires and behavioral tasks
(Reynolds, Ortengren, Richards, & de Wit, 2006). Both types of measures have
advantages and disadvantages (Moeller et al., 2001). Self-report measures, for instance,
can help assess an individual’s long-term patterns of behaviors. Additionally, self-reports
allow researchers to obtain data on a variety of different behaviors and thought processes.
One weakness of self-report measures is that they rely on self-report data, which may not
accurately reflect individuals’ true impulsivity levels. Behavioral measures of
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impulsivity are able to circumvent the flaws in self-report. However, behavioral tasks
assess a narrower spectrum of behaviors than self-reports. Further complicating the
decision of how to measure impulsivity, behavioral tasks and self-report questionnaires
do not correlate well (Lane, Cherek, Rhoades, Pietras, & Tcheremissine, 2003). It is
possible that the two types of measures assess different kinds of impulsivity.
Interestingly both self-report questionnaires and behavioral tasks assessing impulsivity
have been found to be associated with substance abuse (e.g., Zuckerman, 1990;
Vuchinich & Simpson, 1998).
In studying substance abuse and addiction, researchers have used various measures of
impulsivity. One of the more common behavioral measures used is delay discounting.
Delay Discounting
Delay discounting is a behavioral model of impulsivity that operates under a
definition that could be called an inability to delay gratification. Specifically, delay
discounting refers to the reduction in subjective value of a reward that is delayed over
time. This process relates to impulsivity because people may sometimes choose a sooner
reward over a later reward, even if the later reward is greater in objective value. Such a
choice (choosing the smaller, sooner reward) is considered impulsive, whereas the
inverse is considered self-control.
Models of delay discounting. Several mathematical models of delay discounting are
described in the literature to date. Exponential discounting (Fishburn & Rubinstien,
1982; Lancaster, 1963) assumes that the subjective value of a reward drops by a fixed
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amount, or exponentially, per unit time delayed. Samuelson (1937) proposed the most
common function used to model exponential discounting:
V = Ae-kD

(1)

where V is the subjective value of the reward, A is the objective value of the reward, D is
the length of the delay until the reward is given, and k is a discounting constant
representing the rate of discounting. Higher k values indicate that an individual discounts
rapidly, or that rewards lose subjective value more quickly for that individual.
Although an exponential model of delay discounting is intuitively sufficient to
explain choice, evidence has suggested that this model may not best describe decisionmaking between immediate and delayed rewards (Chung, 1965; de Villiers & Herrnstein,
1976). Instead, a hyperbolic model of discounting seems to fit behavioral data better.
One of the commonly used models of hyperbolic discounting was posited by Mazur
(1987):
V = A/(1 + kD).

(2)

According to this function, a reward will lose value more quickly at shorter delays than at
longer delays. Similarly to the exponential model, the hyperbolic model of choice can
account for an individual choosing a smaller more immediate reward over a larger
delayed reward.
Given the variety of mathematical models for delay discounting, research has focused
on which models to use. For instance, strong evidence has been gathered against the
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usage of exponential discounting, or Equation 1. Namely, the exponential model cannot
account for preference reversals (Ainslie & Haendel, 1983). If an individual must wait
some time before either reward can be obtained, he or she may initially choose the
delayed but greater reward. Yet as time grows closer to the sooner but smaller reward,
the individual may opt to switch preference to the reward closer in time. For example, an
individual may have the choice between a concert delayed by sixth months, and a car
delayed by a year. At first, the individual may choose the car, which is the objectively
more valuable choice. However, as time passes, the individual may impulsively switch
preferences to the concert in one month, as opposed to the car in seven months. While
exponential models of discounting cannot mathematically account for preference
reversals, the hyperbolic model can (Kirby & Herrnstein, 1995).
Assessing delay discounting. Assessments of delay discounting vary. Commonly,
research participants will be requested to indicate a series of hypothetical preferences for
a later, larger reward or a smaller, sooner reward (Rachlin, Raineri, & Cross, 1991).
However, studies have also given real rewards to participants. In these studies,
researchers will randomly select responses from participants and give them the amount of
money they choose at the delay indicated (Kirby, Petry, & Bickel, 1999). The purpose of
utilizing a real-rewards delay discounting task is to have participants treat each choice as
personally relevant. This procedure has the advantage of high external validity;
participants are encouraged to demonstrate impulsivity with real rewards. However, the
procedure does have drawbacks. Because any one trial could be the response selected to
have real consequences, researchers must constrain themselves to offer rewards that are
feasible (e.g. $100 instead of $1,000). Furthermore, delays need to be tailored for
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practicality, such that delivery of rewards for delays of 25 years, for example, would be
problematic.
As the usage of real-rewards discounting tasks are designed to have participants
exhibit genuine impulsivity, concern has been raised about whether the usage of
hypothetical rewards generates different discounting rates than real rewards. Indeed,
Kirby (1997) compared hypothetical-rewards studies and real-rewards studies, finding
that individuals discounted real money more than hypothetical money, though both were
still described well by hyperbolic models. However, other studies comparing real and
hypothetical rewards within subjects have not found a difference between real and
hypothetical rewards. (Johnson & Bickel, 2002; Madden, Begotka, Raiff, & Kastern,
2003). Few other studies have compared these two methods of delay discounting
assessment.
Another method in which delay discounting tasks can differ is in the commodity of
the reward. Research participants may be asked to indicate intertemporal preference for
small and large health gains (Chapman & Elstein, 1995), drugs (Field, Santarcangelo,
Sumnall, Goudie, & Cole, 2006), or other relevant rewards (Van den Bergh, Dewitte, &
Warlop, 2008) instead of or in addition to money. For instance, Baker, Johnson, and
Bickel (2003) compared smokers and non-smokers on discounting rates for health,
money, and in the case of smokers, cigarettes. In order to obtain an equivalent value of
health gains or cigarettes for a given value of money, the researchers asked participants
during the first experimental session to associate amounts of money to number of
cigarette packs and length of improved health. No significant differences were found
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within the two groups between monetary and health gains. However, smokers discounted
cigarettes at a higher rate than they discounted both money and health gains. Therefore,
delay-discounting tasks may be modified to incorporate rewards more personally relevant
to participants.
Analysis of delay discounting. Analysis of delay discounting involves calculating
indifference points, where the larger delayed reward and the smaller immediate reward
are subjectively worth the same to the individual. For example, $600 available
immediately may be worth the same as $1000 available after a month for a given
individual. The given individual will be equally likely, then, to choose $600 available
immediately as to choose $1000 available after a month. In terms of Equations 1 through
4, the indifference point is the V value for a given delay. Graphing indifference points
over multiple delays yields an indifference curve, where steeper curves indicate more
impulsive decision-making. These curves are fit to the data using nonlinear regression
analyses, from which k and s values are derived.
Myerson, Green, and Warusawitharana (2001) noted problems with using k and s
values. Firstly, k and s values are tied to the mathematical model researchers utilize,
which may differ across studies. Indeed, researchers still debate over which function best
describes delay discounting. Second, distribution of k values is not normal but positively
skewed, which results in statistical problems. Because standard parametric tests assume
normal distribution, non-parametric tests are necessary to make inferences about the
population. Yet non-parametric tests are less powerful than parametric tests (Hays, 1994)
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and are not able to compare groups when other experimental factors also differ (i.e.,
commodity of reward).
To remedy these problems, Myerson and colleagues (2001) have suggested graphing
indifference curves and analyzing the area underneath the curve (AUC). In order to
calculate AUCs, reward values and delays are calculated as proportions of the maximum
used reward and delay, respectively. Then, lines are drawn from data points down to the
x-axis, segmenting the curve into a series of trapezoids. Assuming two data points that
have coordinates of (x1, y1) and (x2, y2), the area of each trapezoid is (x2 – x1) [(y1 + y2)/2].
The areas of all trapezoids are then summed to form an AUC. Lesser areas underneath
the curve of indifference denote more impulsivity, with 0.0 indicating maximum
discounting (highest impulsivity) and 1.0 indicating no discounting (lowest impulsivity).
Unlike k values, AUCs are more normally distributed and are thus suitable for parametric
testing. Furthermore, AUCs are computed using observed data points instead of a curve
fit to the data, which results in a model- and theory-free parameter of delay discounting.
However, Myerson and colleagues (2001) warned that two separate indifference
curves may have different rates of discounting, but the same areas. For instance, an
individual may discount steeply at shorter delays and shallowly at longer delays. Another
individual may discount shallowly at shorter delays and steeply at longer delays. If the
AUCs were computed for these two individuals, the same value may be obtained. To
avoid such confounds, the authors suggest examining the raw data and potentially
computing two AUCs for shorter and longer delays. Despite this potential issue, AUCs
provide a valuable method with which to evaluate delay discounting statistically.
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A variety of delay-discounting models, assessments, and analyses have been
described in the literature. One common usage of delay-discounting tasks has been to
understand the role of impulsive decision making in addiction.
Using delay discounting to study addictive behaviors. Impulsive decision making
occurs frequently among those who exhibit addictive behaviors. As an example, an
individual may often choose to engage in drug use (a small immediate reward) over
delayed but larger incentives such as good health or financial stability. Due to the
parallels between delay discounting and drug use, many studies have used delay
discounting as a framework for understanding the relation between addiction and
impulsivity.
Gambling. Dixon, Marley, and Jacobs (2003) administered a delay-discounting task
to individuals gambling at an off-track betting facility for horse races. Potential
participants were first screened using the South Oaks Gambling Screen (SOGS).
Individuals scoring above a 4 on the SOGS (which is associated with pathological
gambling) were asked to indicate preference between a series of two hypothetical money
amounts, one immediate and one delayed. Immediate amounts ranged between $1 and
$1000, and delays ranged from 1 week to 10 years. The researchers found that the
hyperbolic model of delay discounting did not always provide a good fit, due to
individual variability. However, gamblers generally had higher rates of discounting
when compared to non-gambling controls sampled from the surrounding community.
Furthermore, the mean AUC for aggregate indifference points was significantly lower for
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gamblers than non-gamblers. These results suggest that gamblers are more impulsive
than non-gamblers.
Delay discounting has also been used to examine comorbid gambling and substance
use. For instance, Petry (2001) examined gamblers with and without substance use
problems as compared to controls. Petry found that gamblers without comorbid
substance abuse discounted more rapidly than non-gambling controls. Furthermore,
gamblers with comorbid substance abuse discounted more rapidly than gamblers without
comorbid substance abuse. In other words, there is an interaction between substance-use
and gambling associated with higher rates of discounting than simply gambling. This
finding replicates results of a previous study (Petry & Casarella, 1999).
Illicit drugs. Cocaine abusers have also been studied with respect to delay
discounting. Hiel, Johnson, Higgins and Bickel (2006) studied cocaine abusers, former
cocaine abusers, and controls. Participants were recruited from outpatient treatment at a
university-based research clinic. Hiel and colleagues found that there were no significant
differences in the discounting of money between all three groups. However, when
collapsing the current cocaine users and the former cocaine users, researchers found that
individuals who had ever used cocaine discounted money more steeply than non-using
controls.
Another study examined delay discounting in heroin addicts. Kirby and colleagues
(1999) recruited heroin addicts from a campus-based outpatient clinic, whereas controls
were recruited from the local community. Participants completed self-report measures of
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impulsiveness, as well as a delay-discounting task. The researchers found that heroin
addicts discounted roughly twice the rate of non-drug-using controls.
Cigarette smoking. Other studies have examined delay discounting in cigarette
smokers. Bickel, Odum, and Madden (1999) examined discounting in current, never, and
ex-smokers. To qualify as a current smoker, individuals must have reported smoking at
least 20 cigarettes a day for the past 5 years; ex-smokers must have abstained from
similar levels of smoking for a year. Participants completed a delay discounting task
involving monetary values. Current smokers completed an additional delay discounting
task involving amounts of cigarettes instead of monetary values. The researchers found
that current smokers discounted money more steeply than never or ex-smokers.
Furthermore, smokers discounted cigarettes at a steeper rate than they discounted money.
The researchers also found that ex-smokers discounted very similarly to never-smokers,
suggesting that the impulsivity associated with current smokers is dynamic.
Johnson, Bickel, and Baker (2007) replicated these findings in individuals smoking
fewer than 20 cigarettes a day, more than 20 cigarettes a day, and non-smokers.
Participants completed three laboratory sessions, one assessing health gains and losses
and cigarette gains and losses, and two sessions using hypothetical monetary choices.
During these later sessions, participants performed a computer-administered delay
discounting task. Gains and losses were represented in the delay-discounting paradigm.
The researchers found that light smokers discounted cigarettes similarly to heavy
smokers, and both discounted money more than non-smokers.
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The studies mentioned above used discounting of cigarettes to compare groups of
smokers. Yet the researchers did not control for cigarette satiation and deprivation,
which could influence how quickly smokers discount cigarettes. To investigate satiation
and deprivation, Field and colleagues (2006) conducted a study examining the effects of
nicotine deprivation on delay discounting. Individuals who smoked daily completed two
sessions, one after at least 13 hrs of cigarette deprivation, and one where participants
could smoke freely beforehand. The researchers found that individuals discounted both
money and cigarettes more rapidly under the deprivation condition than under the free
condition. This suggests that impulsive decision-making may be more evident under
deprived conditions. Conversely, self-control may be greatest in addicted individuals
after, or perhaps during, drug usage, due to the reinforcing effects of the drug.
Problem drinking. Researchers have used delay discounting as a framework for
understanding problematic alcohol drinking. Petry (2001) studied alcoholics, currently
abstinent alcoholics, and non-abusers. Participants responded to a delay-discounting task
with delayed rewards consisting of $1000, $100, 15 bottles of preferred wine or liquor,
and 5 bottles of preferred wine or liquor. Petry found that alcoholics discounted money
more quickly than controls. Currently abstaining alcoholics discounted less than
alcoholics, yet more than non-abusers. When comparing the discounting of money to the
discounting of bottles of alcohol within groups, Petry found that alcohol was discounted
more rapidly than money. In another study, Field, Christiansen, Cole, and Goudie (2007)
examined adolescent light and heavy drinkers in the United Kingdom. Drinking
endorsement was collected from potential participants and was used to form the light
drinking group (lowest 25%) and the heavy drinking group (highest 25%). Participants
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then completed a paper version of the delay discounting task. The researchers found that
heavy drinkers discounted more rapidly than light drinkers.
Not all studies have found that alcohol abuse is associated with increased discounting.
Wilhelm, Reeves, Phillips, and Mitchell (2007) compared two strains of rats on a delay
discounting task and a go/no-go task, another measure of behavioral impulsivity.
Rodents were bred to voluntarily drink either low or high amounts of 10% ethanol. Rats
could choose via nose-poke between a large amount (20 µl) of sucrose after a delay
ranging from 0 to 12 s or a small amount (10 µl) immediately. The go/no-go task used a
light to signal go trials and a tone and light to signal no-go trials. Rodents were to refrain
from nose-poking on no-go trials and were to nose-poke on go trials; more nose-pokes on
no-go trials indicated higher impulsivity. Wilhelm and colleagues found that light
drinking and heavy drinking rodents did not differ on the delay-discounting task, though
heavy drinking rodents did make more pre-cue responses to go trials than light drinking
rodents. The researchers suggested that the genetic manipulation of drinking preference
in rodents may be unrelated to the inability to delay gratification.
In a study with humans, Richards, Zhang, Mitchell, and de Wit (1999) assessed the
effects of alcohol on delay discounting. Participants recruited from a university and the
surrounding community attended four sessions: an orientation, two experimental sessions
(alcohol/placebo), and debriefing. In experimental sessions, participants completed a
predrug computerized delay-discounting task. This task was programmed to titrate
towards individuals’ indifference points for given delays. Then, participants drank 0.5 g
kg-1 alcohol, 0.8 g kg-1 alcohol, or placebo. Participants were given twenty minutes for
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the drug to take effect. Finally, participants completed the same computerized delaydiscounting task, and were driven to their homes. Experimental conditions were
counterbalanced between participants. The researchers found no significant differences
between alcohol conditions and the placebo condition. The researchers suggested that the
effects of alcohol may be more evident under conditions of high conflict, where both
gains and potential losses are larger.
One study found that alcohol intoxication reduces delay discounting. Ortner,
MacDonald, and Olmstead (2003) examined the effects of alcohol, placebo, and control
(sober) on delay discounting. Undergraduate students were given either three mixed
alcoholic drinks, non-alcoholic drinks with rims dipped in alcohol (placebo), or were
assigned to control. Then, they completed a delay-discounting task with a delayed
reward of $10 and immediate values ranging from $.01 to $10.50. The researchers found
that indifference points for students in the alcohol and placebo conditions were higher
overall than for students in non-alcohol conditions. Ortner and colleagues suggested that
perhaps the artificialness of the experimental session inhibited individuals from behaving
uninhibitedly in regards to choice in rewards.
Caffeine and impulsivity. Few studies have looked at caffeine’s influence on
impulsivity and even fewer have used a delay discounting paradigm. Roehrs, Greenwald,
and Roth (2004) examined the effects of ethanol, sleepiness, and caffeine on a risk-taking
measure, the Stop-Light Task. This task involves typing various x-y key combinations
during a ―green light‖ for actual monetary gain. Once the ―yellow light‖ appeared,
participants could choose to not complete the remainder of the combinations, which
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would conserve their earnings, or they could choose to continue, risking their current
earnings. Adult participants were identified as either alert or sleepy, based on monitored
sleep patterns. Participants then attended multiple sessions where they received a
combination of caffeine (0.0 mg, 150.0 mg, or 300.0 mg) and ethanol (0.0 g kg -1 or 0.5 g
kg-1). Sessions were separated by 3 to 7 days so participants could be tested withinsubjects, as well as between groups (alert or sleepy). After the combination of ethanol
and caffeine took effect, participants completed the Stop-Light Task. However, no
significant effects for risky choices were found for ethanol or caffeine or any of their
interactions.
Jones and Lejuez (2005) conducted a study examining the personality correlates of
caffeine consumption. College students were screened for high and low levels of caffeine
consumption, as well as caffeine dependence, using the Caffeine Consumption
Questionnaire (Shohet & Landrum, 2001). Two groups of participants were then formed:
non-caffeine-dependent low consumers and caffeine-dependent high consumers.
Participants then completed three personality measures of impulsivity: the SensationSeeking Scale (Zuckerman, Eysenck, & Eysenck, 1978), the Eysenck Impulsiveness
Scale (I7; Eysenck, Pearson, Easting, & Allsopp, 1985), and the Balloon Analogue Risk
Task (BART). The researchers found that high sensation-seeking and impulsivity scores
were significantly correlated with being caffeine-dependent high consumers. However,
when sensation-seeking and impulsivity scores were entered into a logistic regression,
only sensation-seeking could significantly predict group status. These findings suggest
that caffeine consumption may be associated with sensation-seeking, though not with
risk-taking or impulsivity.

15
Marczinski and Fillmore (2003) examined the effects of different doses of caffeine
(0.0 mg kg-1, 2.0 mg kg-1, and 4.0 mg kg-1) combined with different doses of alcohol (0.0
g kg-1, and 65.0 g kg-1) on a cued go/no-go behavioral inhibition task. Cues were
consistent with go/no-go targets on roughly 80% of trials. Participants consisted of social
drinkers recruited from the local community. Alcohol generally lengthened the response
times for go targets with the no-go cue. However, the researchers found that 4.0 mg kg -1
caffeine shortened back to baseline the response times to go targets with no-go cues
under the alcohol condition. The researchers also found that caffeine alone shortened
response times to go targets with go cues. Caffeine was not found to have any main
effect or interaction effect for failure to suppress responses on no-go targets. These
findings suggest that while caffeine may not influence impulsivity in terms of failing to
suppress a predominant motion, caffeine may aid in decreasing response speed.
Childs and de Wit (2006) investigated the effects of caffeine (placebo, 50 mg, 150
mg, or 450 mg) on subjective, physiological, and behavioral measures. Participants were
college students who endorsed low and non-dependent usage of caffeine, due to the
difficulty of assessing the effects of caffeine in individuals who have developed a
tolerance. Participants were given a version of the go/no-go task as a measure of
behavioral disinhibition. However, no significant effects of caffeine were found for
failure to inhibit responses.
Meyer and Caston (2004) examined the interactive and main effects of stress and
caffeine on investigatory behaviors and behavioral disinhibition (impulsivity) in mice.
Eighty mice were divided into two groups: stressed and unstressed. Stressed mice
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underwent stressful procedures for six consecutive days, which included: submersion in
cold water; placement in an open, lit field; and placement in a confined tube.
Furthermore, the two groups were divided into four caffeine groups (saline, 30 mg kg -1,
60 mg kg-1, or 120 mg kg -1). Stressed and unstressed mice were injected with either
saline or caffeine on the sixth day following the stressful procedure. Behavioral
measures of investigation and inhibition were assessed by placing mice in a
parallelepipedic container. Behaviors that indicated investigation included walking time
and rearing behaviors, whereas time spent in the center of the device and time spent
frozen in the periphery of the device served as measures of disinhibition. Specifically,
more time spent in the center and less time spent frozen in the periphery indicated higher
levels of disinhibition. The researchers found that unstressed mice injected with 30 mg
kg-1 caffeine walked more often in the center zone of the device (behavioral disinhibition)
than mice injected with saline, though this was not found for higher levels of caffeine.
However, this effect did not quite meet statistical significance. Furthermore, stressed
mice showed only non-significant increases in behavioral disinhibition. The results from
this study imply that caffeine may increase behavioral disinhibition in the rodent, though
more studies need to be conducted to find this effect.
Diller, Saunders, and Anderson (2008) conducted one of the few delay discounting
studies of caffeine. The researchers injected acute levels (10 mg, 17 mg, and 30 mg,
counterbalanced) of caffeine into male rats trained to engage in delay-discounting tasks.
Specifically, rodents had the opportunity to press one lever to obtain 1 pellet of food
immediately, or another lever to obtain 3 pellets after a delay. Delays ranged from 0 to
16 s. Rodents injected with caffeine preferred the delayed reward more often than
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controls, resulting in higher indifference points and areas under the curve (AUC).
Indifference points and AUCs were higher in higher doses. In a second phase of the
study, Diller and colleagues examined the effects of chronic administration of 30 mg of
caffeine on delay discounting. They found that chronic administration resulted in
lowered mean indifference points and AUCs, though both were still higher than saline
controls. These results suggest that acute administrations of caffeine in rodents decrease
impulsivity in a dose-dependent manner. Chronic administration of high doses heightens
impulsivity, though not to baseline levels.
Upon examination, the literature suggests that a relation exists between drug abuse
(or other addictive behaviors) and impulsivity. Problematic drug users are generally
more likely to choose a smaller, sooner reward over a greater, delayed reward. However,
few studies have experimentally examined the effects of drug state on delay discounting.
In other words, little research has been done on individuals while intoxicated by a given
drug. Furthermore, one of the most commonly used drugs in the world, caffeine, has not
been studied under the delay-discounting model of impulsivity in humans. Caffeine is an
important drug to consider under the delay-discounting paradigm for reasons that will
become apparent after a short review of the drug.
Caffeine
Caffeine, or 1,3,7-trimethylxanthine, is found naturally in various forms, such as in
coffee, chocolate, and tea. It is also added to other consumables such as soda and energy
drinks. An estimated 80% of the American population consumes caffeine daily,
regardless of source (Barone & Roberts, 1996; Bonham & Leaverton, 1979). Daily levels
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of caffeine consumption for the average individual in the US range from 275 mg (Lane,
1983) to 3 mg kg-1 (Barone & Roberts, 1996).
Few studies have assessed the reasons individuals consume caffeine. Graham (1988)
modified an alcohol consumption model for usage for caffeine. Motives included two
―personal‖ reasons (stimulant and relief) and two ―social‖ reasons (beverage and to be
sociable). She found that both personal motives were the best predictors of caffeine
consumption, with beverage motives being a strong predictor. Heinz, Kassel, and Smith
(2009) developed a Caffeine Expectancy Questionnaire (CEQ) under the theory that
expectancy of outcomes underlies caffeine’s reinforcing effects. This measure comprised
of four factors including withdrawal symptoms, positive effects, acute negative effects,
and mood effects. The researchers found adequate validity for the measure, though
cautioned that more studies are needed to assess the instrument’s reliability.
Physiological effects. Caffeine has a wide variety of physiological effects. Caffeine
exerts its effects in the brain through the blockage of adenosine receptors (Daly &
Fredholm, 1998). Adenosine is a neurotransmitter that modulates the responses mediated
by other neurotransmitters and commonly produces sedative effects that caffeine inhibits
(Cauli & Morelli, 2005; Dunwiddie & Worth, 1982). In roughly 30-45 min, caffeine
reaches peak concentration levels (Denaro & Benowitz, 1991). Caffeine metabolizes into
three main compounds (Benowitz, 1990). The primary metabolite of caffeine is
paraxanthine, with other metabolites being theobromine and theophylline. These
metabolites are pharmacologically active in the body, which may contribute to the effects
of caffeine.
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One of the more commonly recognized effects of caffeine is on sleep. Evidence has
found that, when consumed before trying to sleep, caffeine can delay the onset of sleep
(Zwyghuizen-Doorenbos, Roehrs, Lipschutz, Timms, & Roth, 1990), as well as reduce
the duration of sleep (Hicks, Hicks, Reyes, & Cheers, 1983). However, wide individual
differences exist. Levy and Zylber-Katz (1982) found that individuals who reported no
difficulty sleeping after caffeine intake metabolized caffeine more quickly than
individuals who reported sleep difficulties after caffeine consumption. Other studies
found that even morning caffeine intake can influence sleep at night (Landolt, Werth,
Borbely, & Dijk, 1995). Some authors have suggested that heavy coffee drinkers develop
a tolerance to the effects of caffeine on sleep (Colton, Gosselin, & Smith, 1968), though
the literature has been ambiguous on the topic (Smith, 2002).
Caffeine can aversively affect the cardiovascular system at some doses. Specifically,
while caffeine has little effect on heart rate, both systolic and diastolic blood pressure rise
by 5 – 15 mmHg and 5 – 10 mmHg respectively, usually at higher doses (Noordzij et al,
2005). Although some research has suggested that physiological tolerance of the drug
can moderate the effects on blood pressure, empirical support for this claim is conflicted
(James, 2004). Research has also examined the effects of long-term caffeine use on heart
disease through epidemiological studies (Cornelis & El-Sohemy, 2007). Generally,
results show that caffeine may serve as a risk factor in coronary heart disease. Findings,
however, have been conflicted due to methodological differences in data collection and
not controlling for confounds.
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Psychological effects of caffeine. Research on the effects of caffeine has not been
limited to physiological domains; the psychological actions of caffeine have been
examined as well. General psychological effects of caffeine include improved alertness
(Regina, Smith, Keiper, & McKelvey, 1974), memory (Smith, Sturgess, & Gallagher,
1999), and reaction time (Durlach, 1998) at some doses. Caffeine has also been shown to
increase subjective ratings of stress (Lane, 1983). Research has commonly examined the
effects of caffeine on mood, anxiety, and whether caffeine is addictive.
Mood. Studies on the effects of caffeine on mood states have yielded conflicting
results. Some studies report that caffeine elevates mood. For instance, Childs and de Wit
(2008) conducted a study in which volunteers from the community and university were
deprived of sleep for over 12 hrs. Participants were required to wake up at 7:00 am and
to attend the laboratory sessions beginning at 5:00 pm. At 3:30 am, participants
completed mood ratings and performance tasks and were given either caffeine pills (200
mg) or placebo pills. Then, mood ratings were assessed every 30 min after until 5:00 am.
The researchers found that caffeine raised positive mood and friendliness ratings and
lowered depression ratings.
However, Veleber and Templar (1984) found the opposite. Participants recruited
from colleges and businesses were given 0, 150, or 300 mg of caffeine per 45.36 kg of
body weight. Mood ratings were collected before and after the drug took effect. The
researchers found that depression, anxiety, and hostility ratings increased from preconsumption to post-consumption. In discussing these results, the researchers postulated
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that caffeine produces an initial elation in mood which is followed by a depression,
similar to other psychoactive stimulants such as amphetamine.
Anxiety. Studies generally show that caffeine in moderate to large doses can induce
anxiety in non-clinical samples (Hughes, 1996). For example, Loke (1988) assessed the
effects of 0, 200, and 400 mg of caffeine on anxiety in undergraduates. After caffeine
administration, participants completed subjective mood ratings and memory tasks.
Participants reported dose-dependent increases in nervousness, tension, and anxiety. Few
studies have found a non-effect of caffeine on anxiety, though exceptions exist (James,
Crosbie, & Paull, 1987).
Research has also been conducted in individuals with anxiety disorders. Intuitively,
individuals with anxiety disorders may consume less caffeine than others, as the effects
of caffeine may mimic or induce anxiety. Indeed, Lee, Cameron, and Greden (1984)
found that 84% of anxious inpatients consumed less than 249 mg of caffeine per day, as
opposed to 41% of other inpatients. When such individuals are exposed to moderate
levels of caffeine (3.3 mg kg-1) they report significantly higher anxiety responses than
non-anxious controls (Totten & France, 1995).
Caffeine as an addictive drug. With the widespread usage of caffeine, concern has
been raised over whether caffeine is addictive. Indeed, some have considered caffeine as
a model drug of abuse (Holtzman, 1990). In general, the research suggests that usage of
caffeine at low to moderate doses is non-problematic (James & Paull, 1985). However, at
high doses, individuals can become intoxicated by caffeine.
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Caffeine intoxication has also been referred to in the literature as caffeinism, caffeine
overdose, and caffeine poisoning. Generally, caffeine intoxication is associated with
symptoms such as irritability, nervousness, headache, reflex hyperexcitability, and
tachypnea (APA, 1994). These symptoms raise important diagnostic concerns, as they
can resemble symptoms associated with anxiety disorders (Greden, 1974). Caffeine
intoxication can occur in some individuals at doses exceeding 500 mg, while the lethal
dose in human is estimated to be roughly 10 g (Stavric, 1988). Cases of death resulting
from caffeine intake have been reported, both accidentally and as a method of suicide
(Kerrigan & Lindsey, 2005; Holmgren, Norden-Pettersson, & Ahlner, 2004).
Individuals who consume caffeine regularly may also experience withdrawal
symptoms upon abrupt cessation. Schuh and Griffiths (1997) conducted a study on the
symptoms of caffeine withdrawal in humans. On average, participants recruited for the
study consumed an average daily amount of 379 mg of caffeine. Upon abstinence from
caffeine for 19 hrs, participants reported headaches, fatigue, lack of well-being, and
unhelpfulness. Such symptoms are commonly reported in the literature, along with
depression, nausea, muscle aches, and difficulty concentrating (Griffiths & Woodson,
1988a). These symptoms occur roughly 12-24 hrs after termination of chronic or acute
caffeine consumption, though the symptoms can vary individually in severity (Juliano &
Griffiths, 2004).
Research on tolerance to caffeine’s effects has been inconclusive. Much research has
studied whether tolerance can be developed for caffeine’s effects on blood pressure. An
early study by Robertson, Wade, Workman, Woosley, and Oates (1981) found partial
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tolerance to caffeine-related increases in blood pressure over a period of 3 days. Other
studies have replicated this finding and suggested possible mechanisms of tolerance
(Colton et al., 1968; Shi, Benowitz, Denaro, & Sheiner, 1993). However, a large body of
literature also exists finding no tolerance to the cardiovascular effects of caffeine
(Hartley, Lovallo, Whitsett, Sung, & Wilson, 2001; James, 2004). More research on the
tolerance of caffeine’s hemodynamic effects is needed. Other research has focused on
the tolerance to effects on sleep (Snel, 1993), finding equivocal results. Studies of
tolerance to caffeine’s effects on mood have generally found either no tolerance (Estler,
1982) or tolerance to some negative effects such as headache and fatigue (Evans &
Griffiths, 1992).
Studies have shown that caffeine reinforces its usage at low and moderate doses
(Rush, Sullivan & Griffiths, 1994; Hughes, Oliveto, Bickel, Higgins, & Badger, 1995).
At higher doses (300 mg 70 kg-1), caffeine can induce discomfort and aversive effects
(Garrett & Griffiths, 1998). The reinforcing properties of caffeine can be associated with
avoidance of withdrawal symptoms, but can also be independent of withdrawal
(Silverman, Mumford, & Griffiths, 1994). However, these reinforcing effects are often
weaker than other drugs (Griffiths & Woodson, 1988b).
Present Study
Caffeine is the most commonly consumed drug in the world. Furthermore, a review
of the literature suggests that consumption of caffeine can have potentially adverse
psychological, as well as physiological, effects. Though the research is not clear whether
caffeine is addictive, effort should be made to understand possible implications of
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caffeine addiction. While many drugs are correlated with high levels of impulsivity,
research suggests that caffeine may only be related to certain types or measures of
impulsivity, if at all. Only one study to date has used delay-discounting tasks to model
the effects of caffeine on impulsivity (Diller et al., 2008). It is important to examine
delay discounting in humans to obtain a behavioral measure of inability to delay
gratification, which may underlie addictive behaviors. Furthermore, delay discounting
should be examined while individuals are under the effects of caffeine.
The goal of this study is to examine caffeine’s influence on delay discounting in
humans. Participants performed a delay-discounting task after having ingested a placebo
or caffeine. Comparisons were made within participants as each individual underwent
both placebo and caffeine trials. As assignments to placebo and caffeine were crossbalanced, comparisons were made between orders of assignments as well.

Method
Participants
Participants were 28 undergraduate students (18 men, 10 women) at James Madison
University (JMU). The majority of participants were Caucasian (54% White, 4%
Black/African American, 4% Hispanic, 7% Other, 32% Not-Specified). Inclusion criteria
included being at least 18 years of age and endorsing little to no caffeine consumption on
an online screener survey. Potential participants who endorsed consuming more than an
average of 12 oz of cola or tea per day or 5 oz of coffee per week were excluded from
participation. Furthermore, individuals were excluded if they reported smoking, illicit
drug use, or taking prescription drugs (with the exception of birth control). Women who
were pregnant or were attempting to become pregnant were also excluded, as were
individuals whose body mass index (BMI) was below ―normal‖ or above ―overweight.‖
If individuals endorsed having medical conditions that might be exacerbated by caffeine
consumption (e.g., allergy to caffeine, high blood pressure), they were excluded from the
study.
Participants were recruited through the JMU Psychology Department’s online
participant pool. If potential participants met inclusion criteria based on responses to the
online screener, they were contacted via email to schedule an appointment for two
laboratory sessions. Those who completed both sessions of the study were given 3 hrs of
course credit: 1 hr for the first session and 2 hrs for the second session.
Design
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Participants completed two laboratory sessions in a repeated-measures design. In one
session, participants were given 200 mg of caffeine, dissolved in orange juice. In the
other session, participants were given a placebo, consisting of only the orange juice.
Participants were randomly assigned to receive either caffeine or placebo the first
session, and the order of conditions was counterbalanced across participants. Caffeine
administration was double-blind; neither the participant nor the administrator knew to
which condition the participant was assigned. Between 4 days and 1 week passed
between sessions; participants were encouraged to schedule sessions on the same day of
the week and at the same time.
Measure
During the laboratory sessions, seven participants completed a computerized version
of the Hypothetical Money Choice Task (HMCT: Richards et al, 1999), which is a
titrating version of the delay-discounting task (Holt, Myerson, & Green, 2003), and is
designed to converge towards an individual’s indifference point for a given delay and
delayed amount of money. On each trial, participants were given the choice between two
different amounts of hypothetical money: a small reward available immediately, and a
large reward delayed by an amount of time ranging from 1 week to 25 years.
On this task, participants’ responses determined the next immediate reward presented
(Estle, Green, Myerson, & Holt, 2006). If participants chose the smaller but more
immediate reward, for instance, the next immediate reward would be reduced in amount
by one-half the difference between the two reward values. Likewise, if participants chose
the larger delayed reward, the next immediate reward would be increased in amount by
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one-half the difference. For instance, if the participant first chose $500 available
immediately over $1000 available after a delay, the next choice would be between $250
available immediately (one-half the difference between $500 and $1000) and $1000
available after a delay. Alternatively, if the same participant instead first chose $1000
delayed in time over $500 available immediately, the next choice would be between $750
available immediately or $1000 available after a delay.
After the first choice, the adjustment in the immediate choice was one-half of the
previous adjustment. Therefore, if the second choice was between $250 available
immediately or $1000 delayed, because the last adjustment was $250 subtracted from
$500, the next adjustment would be $125 added to or subtracted from the immediate
amount. If the participant chose $250 for the second choice, then the third choice would
be between $125 available immediately and $1000 delayed in time. Alternatively, the
choice could be between $375 available immediately versus $1000 delayed. The final
indifference point was one-half of the previous adjustment added to or subtracted from
the last amount available immediately. Each delay is represented by six choices, or six
adjustments (see the Appendix for an example of the titration process).
The other 21 participants received an alternate version of the computerized HMCT
(Field et al., 2006). This version, instead of titrating towards an individual’s indifference
point for a given delay, uses a crossover method. In this method, a series of 27 choices
for each delay is presented to participants at random. When data are sorted by immediate
amount and delay, participants will often choose the larger later reward up to a certain
point, where they crossover and begin choosing the smaller sooner reward. The average
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of the amount before and after the crossover serves as the indifference point (see the
Appendix for an example sorted sequence of immediate amounts).
Procedure
At the start of a session, a research assistant read and presented informed consent to
the participant. Then the participant was weighed (for BMI) and connected to Criticare
Systems for physiological measurement. A baseline reading of blood pressure and heart
rate was taken while the participant watches episodes of the television show ―Friends.‖
After 10 min, placebo or 200 mg caffeine was given to the participant in orange juice.
Participants were given 5 min to consume the orange juice. The participant then
continued to watch ―Friends‖ for 30-45 min while the caffeine took effect. After
participants finished watching ―Friends,‖ they began the HMCT computerized delaydiscounting task. Sessions ran between 1-1.5 hrs. If the participant experienced
discomfort or had an elevated blood pressure or heart rate, the research assistant offered
to play a relaxation tape until vitals returned to a safe level.

Results
Due to technical complications, complete data from two participants (15 and 16) were
lost, as were partial data from two other participants (13 and 21). Furthermore, two
participants (18 and 28) were excluded for other reasons (failure to meet BMI criteria and
apparent intoxication, respectively). Indifference points for the remaining 24 participants
were calculated (as described above). The hyperbolic discounting model (Mazur, 1987)
was then fit to the group and individual data. The group R2 values under caffeine and
placebo were .99 and .96, respectively. Furthermore, the median R2 values for
participants under caffeine and placebo were .83 and .87, respectively. Together, these
data suggest that Mazur’s hyperbolic model did a nice job of describing the group data as
well as most individual cases (see Table 1 for individual k and R2 values). In 11 cases
involving 8 participants, though, fit indices were less than .10. These poor fits
demonstrated that some participants discounted delayed rewards in a non-systematic
fashion; they also show that the hyperbolic model does not always do a good job
describing individual data (e.g., Green, Myerson, & McFadden, 1997).
Next, to further screen for individuals who exhibited non-systematic discounting
(i.e., response patterns that did not follow the typical negatively accelerated pattern
observed in many studies of delay discounting), Johnson and Bickel’s (2008) algorithm
was utilized. In accordance with their algorithm, participants with (a) any indifference
point greater than the one preceding it by an amount of 20% of the delayed reward (i.e.,
an indifference point that was at least $200 greater than the preceding indifference point),
or (b) participants having a final indifference point not less than the first indifference
point by an amount of 10% of the delayed reward (i.e., if the last indifference point was
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not at least $100 less than the first indifference point), were excluded. In using this
algorithm, if a participant demonstrated non-systematic discounting in either or both lab
sessions, that participant was excluded from further analysis. This resulted in the
exclusion of an additional seven participants (1, 4, 7, 12, 14, 20, and 23), many of whom
had indices of fit near zero. Therefore, the following analyses were performed on the
remaining 15 participants (8 men, 7 women). Like the full sample, the majority of
participants were Caucasian (47% White, 7% Black/African American, 7% Hispanic,
13% Other, 27% Not-Specified).
Although the derived k parameters from the discounting functions are useful for
describing the form and fit of a curve, as previously mentioned, they do not always do a
good job of describing individual cases of discounting. Moreover, derived k values make
theoretical assumptions about the shape of the discounting function; the purpose of this
study, however, was not to provide the best fit to the data, but rather to compare
discounting rates under caffeine and placebo (i.e., no caffeine) conditions. Therefore,
instead of using k values, AUCs (described above), which provide an atheoretical
measure of discounting (Myerson et al., 2001), were used to compare rates of discounting
between conditions.
First, an independent-samples t test was performed to see whether there was an order
effect (i.e., whether participants discounted differently depending on the order in which
they experienced the conditions). No significant difference in AUC was found between
those participants who received caffeine first and those who received the placebo first,
t(13) = 0.63, p = .53. Another independent t test was performed to determine if there was
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a significant difference between AUCs of those who completed the titrating version of
the HMCT and those who completed the crossover version of the task. No significant
difference was found, t(13) = 0.92, p = .38. Therefore, the data were collapsed into two
conditions: caffeine and placebo.
Next, a dependent-samples t test was performed to examine differences in AUC
between the caffeine and placebo conditions. Average AUC for the caffeine condition
was .30 (SD = .26) and was .36 (SD = .31) for the placebo condition, suggesting that
under caffeine, participants discounted slightly faster (i.e., were more impulsive) than
when they responded under placebo. This difference, however, was not statistically
significant, t(14) = 1.03, p = .32. The results of this analysis are portrayed graphically in
Figure 1.

Discussion
To assess the differences in rates of delay discounting under the influence of caffeine
versus placebo, 15 undergraduate participants completed two laboratory sessions. In one
laboratory session, participants were given 200 mg of caffeine via orange juice. In the
other laboratory session, participants were given just orange juice. In both sessions,
participants completed a delay-discounting task after allowing the caffeine to take effect.
There was no significant difference between caffeine session AUCs and placebo session
AUCs.
This study had two goals: to examine the relation between caffeine and delay
discounting, and to examine the influence of drug state on delay discounting. Although
more research will be needed to clarify the relation between caffeine and delay
discounting, the present study demonstrated that delay discounting can be assessed while
under the influence of a drug. Potentially other measures of impulsivity can be measured
under drug influence as well. Few studies have researched whether influence of a drug
increases or decreases delay discounting. In one of these few studies that examined drug
state, Ortner and colleagues (2006) compared delay discounting in college students given
three mixed drinks (alcohol), non-alcoholic drinks with the rims dipped in alcohol
(placebo), or students assigned to control. The researchers found that individuals in the
placebo and alcohol conditions were less impulsive than controls. More research will be
needed in order to investigate the influence of drug state on delay discounting and
impulsivity in general, and the model used in the present study is a good way to examine
such influences.
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This study suggests that caffeine may not influence impulsivity. These observations
support other findings in experimental studies examining the effects of caffeine on
impulsivity. For instance, Roehrs et al. (2004) compared the effects of 0, 150, and 300
mg of caffeine on a risk-taking task and found no significant differences. Likewise,
Marczinski and Fillmore (2003) gave 0, 2, and 4 mg kg-1 of caffeine to participants and
evaluated their performances on a cued go/no-go behavioral inhibition task. Again, no
differences were observed.
If caffeine does not have an effect on impulsivity, as the present study suggests, it
would differ from other drugs that have been found to influence impulsivity, including
alcohol (Petry, 2001), opiates (Kirby et al., 1999), and cocaine (Hiel et al., 2006). One
possible reason for these differences is that caffeine seems to affect different areas of the
brain. For instance, Nehlig (1999) noted that compared to two other stimulants,
amphetamine and cocaine, caffeine activates different areas in the brain associated with
reward. Specifically, whereas classical drugs of abuse lead to dopamine release in the
nucleus accumbens (the key structure for reward and addiction), caffeine releases
dopamine in the prefrontal cortex. Thus, perhaps this difference in dopamine pathways
may explain drug differences in reward-related behaviors, such as delay discounting.
Although the present findings support some previous research, they also conflict with
other studies. For instance, these results did not support the findings in Diller et al.
(2008), which has been one of few studies to examine caffeine’s effect on delay
discounting. They found that rodents given an acute dose of caffeine (10, 17, and 30 mg)
exhibited less impulsivity as dosage increased. When examining chronic administration
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of caffeine, they found that this effect was lowered, but not back to baseline. This may
indicate a species difference between how humans and rodents are affected by caffeine.
This is doubtful, however, as a body of research has demonstrated that the effects of
caffeine in rodents are comparable to the effects of caffeine in humans (Fredholm, Battig,
Holmen, Nehlig, & Zvartau, 1999; Nehlig, 1999). More research is needed to determine
if caffeine decreases impulsivity, and if so, how.
Differing research methods may provide one possible explanation for these
conflicting bodies of research. Correlative studies have more often found significant
associations between levels of caffeine intake and impulsivity than experimental studies
(e.g., Jones & Lejuez, 2005; Landrum, 1992; Waldeck & Miller, 1997). It may be that
caffeine alone does not cause impulsivity, but another variable, group of variables, or an
interaction of variables mediates the effect. Furthermore, the studies finding a correlation
between caffeine use and impulsivity often used self-report questionnaires, whereas
studies not finding differences between caffeine conditions often used behavioral
measures. Research has shown that behavioral measures of impulsivity may not correlate
with self-report measures (e.g., Lane et al., 2003), which suggests that the two types of
measures may assess different kinds of impulsivity, different constructs altogether, or
different elements of the same construct. Perhaps caffeine may contribute to only certain
kinds of impulsivity.
Another explanation for conflicting research findings is that perhaps a high enough
dosage of caffeine was not used. The effects of caffeine on impulsivity may be evident in
humans only at higher doses. Such dose-dependent responses have been shown in prior
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literature (Diller et al., 2008; Marczinski & Fillmore, 2003). The present study used 200
mg of caffeine, roughly the equivalent of two cups of coffee (Barone & Roberts, 1996).
However, the present study did not ask participants if they experienced the effects of
caffeine on a given trial. These data would be useful because if participants could not
accurately guess whether they received caffeine or placebo, then it is possible they were
not given enough caffeine to experience its effects, which might lead to no differences
between conditions. This explanation is unlikely, though, because participants reported
not being regular consumers of caffeine. Nevertheless, a manipulation check should be
considered for future research.
It is still unclear whether caffeine influences impulsivity. Furthermore, if it does, the
direction of the effect has not yet been confirmed. If caffeine does not affect impulsivity,
as the present study suggests, there may be important clinical implications. Perhaps
simply using a drug may not affect impulsivity. Rather, maybe it is an addiction to drugs
that influences impulsivity. This study and others (e.g., Richards et al., 1999) suggest
that drug state alone may not influence delay discounting, but addiction may (Dixon et
al., 2003). If this is the case, then successful treatments of addiction should be applicable
to any drug addiction or any behavioral addiction.
A secondary implication of this study is that no significant difference was found in
AUCs between a titration delay-discounting task and a crossover delay-discounting task.
This is important experimentally because titration requires fewer trials in order to arrive
at an indifference point. Potentially, students presented with a large number of trials may
lose motivation to complete an experimental task, which may then affect the validity of
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the results (Arvey, Strickland, Drauden, & Martin, 1990; Wolf, Smith, & Birnbaum,
1995). However, because no difference was found in AUCs between the two tasks,
researchers may not have to worry about affecting validity when choosing which delaydiscounting task to use.
This study has a few limitations that need to be considered. This study had a small
sample size, due in part to difficulty finding and recruiting caffeine-naïve students. This
is a small limitation, however, because of the repeated-measures design of the study.
Furthermore, data from some participants were completely or partially lost. Because of
the within-participants design of this study, any participant with only partial data was
completely excluded. Data lost from these individuals may have strengthened or altered
current findings.
Another limitation is that this study did not account for individual variance in
intelligence. Research has suggested that individuals with lower cognitive ability are
more impulsive on delay-discounting tasks than those with higher cognitive ability (see
Shamosh & Gray, 2007). Therefore, it is important to take intelligence into account
when analyzing delay discounting. Future research may consider measuring intelligence
and including the measure as a covariate to verify this assumption.
There is the potential limitation that the homogeneity of the sample influenced
results, as the sample was predominantly Caucasian. Some research has suggested that
Caucasian and African American individuals differ on delay discounting (e.g., de Wit,
Flory, Acheson, McCloskey, & Manuck, 2007). However, due to the repeated measures
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design of the present study, each individual served as their own control. In other words,
individual differences were controlled for experimentally.
The present study has suggested that individuals given a placebo or 200 mg of
caffeine do not differ in delay discounting. However, more research into the effects of
caffeine on delay discounting is needed. Future research should include higher doses to
test for dose-dependent effects. In examining the influence of drug state on delay
discounting or impulsivity, caffeine consumption should be checked chemically through
biological measures. This would ensure that participants only consume caffeine within
the study and that any effect of is due to the given dosage of caffeine, rather than a
combination of caffeine dose from both within and outside the study. Other measures of
impulsivity, both behavioral and self-report, should be compared, and intelligence will
need to be assessed in future studies. Different populations should also be studied to
determine if similar results are found outside of college-aged students.
Furthermore, in order to assess whether drug addiction or drug state influences
impulsivity, a future study could compare caffeine addicts under placebo and under
caffeine. If it is drug addiction, rather than the drug itself that influences impulsivity,
individuals under placebo could be more impulsive due to caffeine deprivation (e.g.,
Field et al., 2006). Together, these potential future studies should provide useful
information on the effects of caffeine on impulsivity.
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Table 1
Indices of Fit and Derived Parameters for the Hyperbolic Discounting Function
ID
1
2
3
4
5
6
7
8
9
10
11
12
14
17
19

Condition
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine

R2
k
0.000
0.000
0.795 64.230
0.993
0.004
0.980
0.003
0.979
0.003
0.895
0.003
0.929
0.001
0.000
0.000
0.902
0.818
0.587
0.623
0.956 12.599
0.899 20.074
0.980
0.023
0.000
6.969
0.979
0.081
0.876
0.155
0.987
0.111
0.962
0.064
0.000
0.003
0.950
0.065
0.000
0.001
0.000
0.005
0.000 318.173
0.696
2.333
0.955
0.000
0.910
0.000
0.841
0.033
0.770
0.007
0.884
0.010
0.981
0.168
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20
22
23
24
25
26
27
28

No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine
No Caffeine
Caffeine

0.000
0.000
0.640
0.825
0.021
0.000
0.871
0.890
0.690
0.871
0.974
0.974
0.868
0.947
0.581
0.721

30.616
35.025
0.701
0.673
0.000
0.000
2.249
2.345
0.561
0.147
0.012
0.017
0.006
0.015
0.044
0.015

Figure 1. Areas Under the Curve for Placebo and Caffeine Conditions with 95%
Confidence Intervals
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Appendix

Which do you prefer?

$500

$1000 in

today

1 year

(1)

(0)

Figure 2. Example Hypothetical Money Choice
Task (HMCT) stimuli

Table 2
Example Progression through HMCT Titration Trials for 1 Delay

Trial
Trial 1
Trial 2
Trial 3
Trial 4
Trial 5
Trial 6
Final Indifference Point

Immediate
Amount
500.00
750.00
875.00
812.50
843.75
859.38
851.57

Delayed
Amount
1000.00
1000.00
1000.00
1000.00
1000.00
1000.00
1000.00

Amount of
Previous
Adjustment
250.00
125.00
62.50
31.25
15.63
7.81

Participant's
Choice
Delayed
Delayed
Immediate
Delayed
Delayed
Immediate
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Table 3
Example Progression through HMCT Crossover Trials for 1 Delay

Immediate Amount
1
5
10
20
40
60
80
100
150
200
250
300
350
400
450
500
550
600
650
700
750
800
850
920
960
990
1000

Delayed
Amount
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000
1000

Participant's Choice
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Delayed
Immediate
Immediate
Immediate
Immediate
Immediate

Indifference
Point if
Participant
Crosses Over
Here
0.5
3
8
15
30
50
70
90
125
175
225
275
325
375
425
475
525
575
625
675
725
775
825
885
940
975
995
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